The long non-coding RNA PIK3CD-AS2 promotes lung adenocarcinoma progression via YBX1-mediated suppression of p53 pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The long non-coding RNA PIK3CD-AS2 promotes lung adenocarcinoma progression via YBX1-mediated suppression of p53 pathway
Authors
Keywords
-
Journal
Oncogenesis
Volume 9, Issue 3, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-12
DOI
10.1038/s41389-020-0217-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma
- (2019) David J. Voce et al. CANCER RESEARCH
- Disruption of Long Noncoding RNAs Targets Cancer Hallmark Pathways in Lung Tumorigenesis
- (2019) Veronica Davalos et al. CANCER RESEARCH
- Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma
- (2019) Rui Chen et al. Molecular Therapy-Nucleic Acids
- The Circular RNA circPRKCI Promotes Tumor Growth in Lung Adenocarcinoma
- (2018) Mantang Qiu et al. CANCER RESEARCH
- Therapeutic Targeting of Long Non-Coding RNAs in Cancer
- (2018) Gayatri Arun et al. TRENDS IN MOLECULAR MEDICINE
- Estrogen receptor β promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer
- (2018) Weiwei Yu et al. ONCOGENE
- Lung tumors with distinct p53 mutations respond similarly to p53 targeted therapy but exhibit genotype-specific statin sensitivity
- (2017) Frances K. Turrell et al. GENES & DEVELOPMENT
- Targeting noncoding RNAs in disease
- (2017) Brian D. Adams et al. JOURNAL OF CLINICAL INVESTIGATION
- LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation
- (2017) C Zhou et al. ONCOGENE
- Activated Protein C Ameliorates Renal Ischemia-Reperfusion Injury by Restricting Y-Box Binding Protein-1 Ubiquitination
- (2015) W. Dong et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27
- (2015) M Qiu et al. Cell Death & Disease
- Comprehensive molecular profiling of lung adenocarcinoma
- (2014) Eric A. Collisson et al. NATURE
- Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of the lncRNA-p53 regulatory network in cancer
- (2014) A. Zhang et al. Journal of Molecular Cell Biology
- Genome-wide analysis of the human p53 transcriptional network unveils a lncRNA tumour suppressor signature
- (2014) Yolanda Sánchez et al. Nature Communications
- The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage
- (2012) Ali Zhang et al. CELL RESEARCH
- Targeting Mutant p53 in Human Tumors
- (2012) Brian D. Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- LincRNA-p21 Suppresses Target mRNA Translation
- (2012) Je-Hyun Yoon et al. MOLECULAR CELL
- p53 Negatively Regulates the Hepatoma Growth Factor HDGF
- (2011) Y. Sasaki et al. CANCER RESEARCH
- Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters
- (2011) Tiffany Hung et al. NATURE GENETICS
- A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
- (2010) Maite Huarte et al. CELL
- Somatic EGFR mutations and efficacy of tyrosine kinase inhibitors in NSCLC
- (2009) Helena Linardou et al. Nature Reviews Clinical Oncology
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- RBBP6 Interacts with Multifunctional Protein YB-1 through Its RING Finger Domain, Leading to Ubiquitination and Proteosomal Degradation of YB-1
- (2008) Moredreck Chibi et al. JOURNAL OF MOLECULAR BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started